Behind the scenes of innovation
EMBLetc EMBL Grenoble technology teams provide a sneak peek into their latest collaborative project in structural biology services: the complete automation of an integral step in X-ray crystallography.
2023
Getting closer to stopping toxoplasmosis infection
Science Recent studies supported by EMBL Grenoble’s expertise in structural biology research and scientific services have identified Altiratinib as a potential drug to stop toxoplasmosis infection and opened up treatment options against malaria.
2022
science
Two in one: combining MASSIF-1 and CrystalDirect
Lab Matters Researchers and engineers have integrated a CrystalDirect harvester into the fully automated beamline MASSIF-1, a unique combination of structural biology technologies that is now open to external academic users.
2022
lab-matters
MASSIF-1 beamline in Grenoble supports COVID-19 drug discovery
Lab Matters MASSIF-1, run jointly by EMBL Grenoble and the ESRF, is a beamline for macromolecular crystallography. It is used by the research community to study the 3D structure of proteins, which is important for drug development.
2021
lab-matters
Upgraded beamlines at EMBL Grenoble unveiled
Science The beamlines run jointly by EMBL Grenoble and the ESRF reopen today, unveiling significant upgrades that exploit the brand new fourth generation ESRF synchrotron source.
2020
science
MASSIFly efficient
Science MASSIF-1 processes its 10,000th crystal, less than one year after the beamline became operational.
2015
science
No matching posts found
